Advances in treatment of acute sulfur mustard poisoning – a critical review

References

• Abedi A, Koohestani HR, Roosta Z. 2008. The short-term effect of chest physiotherapy on spirometric indices in chemical warfare victims exposed to mustard gas. Armaghane Danesh. 13:71–81.
   Google Scholar
• Adibzadeh MM, Ghazanfari T, Ardestani S, Faghihzadeh S. 2016. Serum level of vitamin D reduces in sulfur mustard-exposed individuals with long-term pulmonary complications. Daneshvar Med. 23:1–10.
   Google Scholar
• Agency for Toxic Substances and Disease Registry (ATSDR). 2014. Medical Management Guidelines (MMGs): Blister Agents: Sulfur Mustard Agent H/HD, Sulfur Mustard Agent. [updated; accessed 2014 December 20]. https://www.atsdr.cdc.gov/mmg/mmg.asp?id=924&tid=191.
   Google Scholar
• Allon N, Chapman S, Shalem Y, Brandeis R, Weissman BA, Amir A. 2010. Lipopolysaccharide induced protection against sulfur mustard cytotoxicity in RAW264.7 cells through generation of TNF-alpha. J Toxicol Sci. 35:345–355.
   PubMed Web of Science ®Google Scholar
• American Burn Association. 2011. Advanced Burn Life Support Course, Provider Manual. Chicago (IL): American Burn Association.
   Google Scholar
• American Burn Association. 2017. Advanced Burn Life Support Course, Provider Manual. Chicago (IL): American Burn Association.
   Google Scholar
• Amir A, Turetz J, Chapman S, Fishbeine E, Meshulam J, Sahar R, Liani H, Gilat E, Frishman G, Kadar T. 2000. Beneficial effects of topical anti-inflammatory drugs against sulfur mustard-induced ocular lesions in rabbits. J Appl Toxicol. 20 Suppl 1:S109–S114.
   PubMedGoogle Scholar
• Amitai G, Adani R, Fishbein E, Meshulam H, Laish I, Dachir S. 2006. Bifunctional compounds eliciting anti-inflammatory and anti-cholinesterase activity as potential treatment of nerve and blister chemical agents poisoning. J Appl Toxicol. 26:81–87.
   PubMed Web of Science ®Google Scholar
• Anderson DR, Byers SL, Vesely KR. 2000. Treatment of sulfur mustard (HD)-induced lung injury. J Appl Toxicol. 20 Suppl 1:S129–S12912.
   PubMedGoogle Scholar
• Anderson DR, Holmes WW, Lee RB, Dalal SJ, Hurst CG, Maliner BI, Newmark J, Smith WJ. 2006. Sulfur mustard-induced neutropenia: treatment with granulocyte colony-stimulating factor. Mil Med. 171:448–453.
   PubMed Web of Science ®Google Scholar
• Anderson DR, Taylor SL, Fetterer DP, Holmes WW. 2009. Evaluation of protease inhibitors and an antioxidant for treatment of sulfur mustard-induced toxic lung injury. Toxicology. 263:41–46.
   PubMed Web of Science ®Google Scholar
• Anderson PD. 2012. Emergency management of chemical weapons injuries. J Pharm Pract. 25:61–68.
   PubMedGoogle Scholar
• Andrew DJ, Lindsay CD. 1998. Protection of human upper respiratory tract cell lines against sulphur mustard toxicity by glutathione esters. Hum Exp Toxicol. 17:387–395.
   PubMed Web of Science ®Google Scholar
• Andrew DJ, Lindsay CD. 1998. Protection of human upper respiratory tract cell lines against sulphur mustard toxicity by hexamethylenetetramine (HMT). Hum Exp Toxicol. 17:373–379.
   PubMed Web of Science ®Google Scholar
• Anumolu SS, DeSantis AS, Menjoge AR, Hahn RA, Beloni JA, Gordon MK, Sinko PJ. 2010. Doxycycline loaded poly(ethylene glycol) hydrogels for healing vesicant-induced ocular wounds. Biomaterials. 31:964–974.
   PubMed Web of Science ®Google Scholar
• Anumolu SS, Menjoge AR, Deshmukh M, Gerecke D, Stein S, Laskin J, Sinko PJ. 2011. Doxycycline hydrogels with reversible disulfide crosslinks for dermal wound healing of mustard injuries. Biomaterials. 32:1204–1217.
   PubMed Web of Science ®Google Scholar
• Arbuthnott K, Barbeschi M, Brennan R, Brett-Major D, Cross C, Fletcher T, Gutschmidt K, Roth C, Smallwood C, Shindo N, et al. 2014. Initial clinical management of patients exposed to chemical weapons. Geneva: World Health Organization.
   Google Scholar
• Arroyo CM, Burman DL, Kahler DW, Nelson MR, Corun CM, Guzman JJ, Smith MA, Purcell ED, Hackley BE Jr., Soni SD, et al. 2004. TNF-alpha expression patterns as potential molecular biomarker for human skin cells exposed to vesicant chemical warfare agents: sulfur mustard (HD) and Lewisite (L). Cell Biol Toxicol. 20:345–359.
   PubMed Web of Science ®Google Scholar
• Arroyo CM, Kan RK, Burman DL, Kahler DW, Nelson MR, Corun CM, Guzman JJ, Broomfield CA. 2003. Regulation of 1-alpha, 25-dihydroxyvitamin D3 on interleukin-6 and interleukin-8 induced by sulfur mustard (HD) on human skin cells. Pharmacol Toxicol. 92:204–213.
   PubMedGoogle Scholar
• Atkins KB, Lodhi IJ, Hurley LL, Hinshaw DB. 2000. N-acetylcysteine and endothelial cell injury by sulfur mustard. J Appl Toxicol. 20 Suppl 1:S125–S128.
   PubMedGoogle Scholar
• Au L, Meisch JP, Das LM, Binko AM, Boxer RS, Wen AM, Steinmetz NF, Lu KQ. 2015. Suppression of hyperactive immune responses protects against nitrogen mustard injury. J Invest Dermatol. 135:2971–2981.
   PubMed Web of Science ®Google Scholar
• Babin MC, Ricketts K, Skvorak JP, Gazaway M, Mitcheltree LW, Casillas RP. 2000. Systemic administration of candidate antivesicants to protect against topically applied sulfur mustard in the mouse ear vesicant model (MEVM). J Appl Toxicol. 20 Suppl 1:S141–S144.
   PubMedGoogle Scholar
• Balali-Mood M, Balali-Mood B, Moshiri M. 2014. Sulfur mustard. In: Wexler P, editor. Encyclopedia of toxicology. 3rd ed. Oxford: Academic Press; p. 427–431. https://doi.org/10.1016/B978-0-12-386454-3.00632-1.
   Google Scholar
• Balali-Mood M, Hefazi M. 2005a. The clinical toxicology of sulfur mustard. Arch Iran Med. 8:162–179.
   Google Scholar
• Balali-Mood M, Hefazi M. 2005. The pharmacology, toxicology, and medical treatment of sulphur mustard poisoning. Fundam Clin Pharmacol. 19:297–315.
   PubMed Web of Science ®Google Scholar
• Balali-Mood M, Hefazi M. 2006. Comparison of early and late toxic effects of sulfur mustard in Iranian veterans. Basic Clin Pharmacol Toxicol. 99:273–282.
   PubMed Web of Science ®Google Scholar
• Balali-Mood M, Hefazi M, Mahmoudi M, Jalali E, Attaran D, Maleki M, Razavi ME, Zare G, Tabatabaee A, Jaafari MR. 2005. Long-term complications of sulphur mustard poisoning in severely intoxicated Iranian veterans. Fundam Clin Pharmacol. 19:713–721.
   PubMed Web of Science ®Google Scholar
• Clinical and paraclinical findings in 233 patients with sulfur mustard poisoning. Proceedings of the Second World Congress on New Compounds in Biological and Chemical Warfare Ghent, Belgium: Rijksuniversiteit; 1986.
   Google Scholar
• Balali-Mood M, Navaeian A. 1986. Clinical and paraclinical findings in 233 patients with sulfur mustard poisoning. In: Heyndrickx Bruno, editor. Terrorism: analysis and detection of explosives. Ghent (Belgium): Rijksuniversiteit-Gent; p. 464–473.
   Google Scholar
• Ball CR, Roberts JJ. 1970. DNA repair after mustard gas alkylation by sensitive and resistant Yoshida sarcoma cells in vitro. Chem Biol Interact. 2:321–329.
   PubMedGoogle Scholar
• Ballantyne B. 1986. Intramuscular prednisolone pretreatment does not influence the dermal lesions induced by topical sulfur mustard. Vet Hum Toxicol. 28:204–206.
   PubMedGoogle Scholar
• Balszuweit F, John H, Schmidt A, Kehe K, Thiermann H, Steinritz D. 2013. Silibinin as a potential therapeutic for sulfur mustard injuries. Chem Biol Interact. 206:496–504.
   PubMed Web of Science ®Google Scholar
• Balszuweit F, Menacher G, Schmidt A, Kehe K, Popp T, Worek F, Thiermann H, Steinritz D. 2016. Protective effects of the thiol compounds GSH and NAC against sulfur mustard toxicity in a human keratinocyte cell line. Toxicol Lett. 244:35–43.
   PubMed Web of Science ®Google Scholar
• Baradaran-Rafii A, Eslani M, Tseng SC. 2011. Sulfur mustard-induced ocular surface disorders. Ocul Surf. 9:163–178.
   PubMed Web of Science ®Google Scholar
• Barillo DJ, Croutch CR, Reid F, Culley T, Sosna W, Roseman J. 2017. Blood and tissue silver levels following application of silver-based dressings to sulfur mustard chemical burns. J Burn Care Res. 38:e818–e823.
   PubMed Web of Science ®Google Scholar
• Barillo DJ, Pozza M, Margaret-Brandt M. 2014. A literature review of the military uses of silver-nylon dressings with emphasis on wartime operations. Burns. 40:S24–S29.
   PubMedGoogle Scholar
• BC Cancer Agency. 2006-03-01. Retrieved 2011-01-01. Amifostine: BC Cancer Agency Cancer Drug Manual. British Columbia Cancer Agency.
   Google Scholar
• Bhat KR, Benton BJ, Ray R. 2006. Poly (ADP-ribose) polymerase (PARP) is essential for sulfur mustard-induced DNA damage repair, but has no role in DNA ligase activation. J Appl Toxicol. 26:452–457.
   PubMed Web of Science ®Google Scholar
• Bhattacharya R, Rao PV, Pant SC, Kumar P, Tulsawani RK, Pathak U, Kulkarni A, Vijayaraghavan R. 2001. Protective effects of amifostine and its analogues on sulfur mustard toxicity in vitro and in vivo. Toxicol Appl Pharmacol. 176:24–33.
   PubMed Web of Science ®Google Scholar
• Black RM, Harrison JM, Read RW. 1997. Biological fate of sulphur mustard: in vitro alkylation of human haemoglobin by sulphur mustard. Xenobiotica. 27:11–32.
   PubMed Web of Science ®Google Scholar
• Bobb AJ, Arfsten DP, Jederberg WW. 2005. N-acetyl-L-cysteine as prophylaxis against sulfur mustard. Mil Med. 170:52–56.
   PubMed Web of Science ®Google Scholar
• Borak J, Sidell FR. 1992. Agents of chemical warfare: sulfur mustard. Ann Emerg Med. 21:303–308.
   PubMed Web of Science ®Google Scholar
• Boskabady MH, Amery S, Vahedi N, Khakzad MR. 2011. The effect of vitamin E on tracheal responsiveness and lung inflammation in sulfur mustard exposed guinea pigs. Inhal Toxicol. 23:157–165.
   PubMed Web of Science ®Google Scholar
• Boskabady MH, Vahedi N, Amery S, Khakzad MR. 2011. The effect of Nigella sativa alone, and in combination with dexamethasone, on tracheal muscle responsiveness and lung inflammation in sulfur mustard exposed guinea pigs. J Ethnopharmacol. 137:1028–1034.
   PubMed Web of Science ®Google Scholar
• Braue EH, Jr., Graham JS, Doxzon BF, Hanssen KA, Lumpkin HL, Stevenson RS, Deckert RR, Dalal SJ, Mitcheltree LW. 2007. Noninvasive methods for determining lesion depth from vesicant exposure. J Burn Care Res. 28:275–285.
   PubMed Web of Science ®Google Scholar
• Carroll LS. 2005. Sulfur mustard: cutaneous exposure. Clin Toxicol (Phila). 43:55.
   PubMed Web of Science ®Google Scholar
• Casbohm SL, Rogers JV, Stonerock MK, Martin JL, Ricketts-Kaminsky KM, Babin MC, Casillas RP, Sabourin CL. 2004. Localization of substance P gene expression for evaluating protective countermeasures against sulfur mustard. Toxicology. 204:229–239.
   PubMed Web of Science ®Google Scholar
• CDC. 2008. Guidance on Emergency Responder Personal Protective Equipment (PPE) for Response to CBRN Terrorism Incidents. Columbia: Centers for Disease Control and Prevention; National Institute for Occupational Safety and Health (NIOSH).
   Google Scholar
• Chemical hazard emergency medical managments (CHEMM). Sep 30 2017. Triage Guidelines. U.S. Department of Health & Human Services.; [accessed 2018]. https://chemm.nlm.nih.gov/triage.htm.
   Google Scholar
• Chevillard M, Lainee P, Robineau P, Puchelle E. 1992. Toxic effects of sulfur mustard on respiratory epithelial cells in culture. Cell Biol Toxicol. 8:171–181.
   PubMed Web of Science ®Google Scholar
• Chilcott RP. 2005. Toxicity of sulphur mustard. Toxicol Appl Pharmacol. 204:99–100; author reply 100.
   PubMed Web of Science ®Google Scholar
• Chilcott RP, Dalton CH, Ashley Z, Allen CE, Bradley ST, Maidment MP, Jenner J, Brown RF, Gwyther RJ, Rice P. 2007. Evaluation of barrier creams against sulphur mustard: (II) In vivo and in vitro studies using the domestic white pig. Cutan Ocul Toxicol. 26:235–247.
   PubMed Web of Science ®Google Scholar
• Chilcott RP, Jenner J, Hotchkiss SA, Rice P. 2002. Evaluation of barrier creams against sulphur mustard. I. In vitro studies using human skin. Skin Pharmacol Appl Skin Physiol. 15:225–235.
   PubMedGoogle Scholar
• Connors TA, Jeney A, Jones M. 1964. Reduction of the toxicity of ‘radiomimetic’ alkylating agents in rats by thiol pretreatment. 3. The mechanism of the protective action of thiosulphate. Biochem Pharmacol. 13:1545–1550.
   PubMed Web of Science ®Google Scholar
• Cowan FM, Broomfield CA. 1993. Putative roles of inflammation in the dermatopathology of sulfur mustard. Cell Biol Toxicol. 9:201–213.
   PubMed Web of Science ®Google Scholar
• Cowan FM, Broomfield CA, Smith WJ. 1992. Inhibition of sulfur mustard-increased protease activity by niacinamide, N-acetyl-L-cysteine or dexamethasone. Cell Biol Toxicol. 8:129–138.
   PubMed Web of Science ®Google Scholar
• Dachir S, Barness I, Fishbine E, Meshulam J, Sahar R, Eisenkraft A, Amir A, Kadar T. 2017. Dermostyx (IB1) – high efficacy and safe topical skin protectant against percutaneous toxic agents. Chem Biol Interact. 267:25–32.
   PubMed Web of Science ®Google Scholar
• Dachir S, Fishbeine E, Meshulam Y, Sahar R, Chapman S, Amir A, Kadar T. 2004. Amelioration of sulfur mustard skin injury following a topical treatment with a mixture of a steroid and a NSAID. J Appl Toxicol. 24:107–113.
   PubMed Web of Science ®Google Scholar
• Dacre JC, Goldman M. 1996. Toxicology and pharmacology of the chemical warfare agent sulfur mustard. Pharmacol Rev. 48:289–326.
   PubMed Web of Science ®Google Scholar
• Darchini-Maragheh E, Balali-Mood M. 2018. Delayed complications and long-term management of sulfur mustard poisoning: recent advances by iranian researchers (Part і of іі). Iran J Med Sci. 43:103–124.
   PubMed Web of Science ®Google Scholar
• Darchini-Maragheh E, Blain PG, Balali-Mood M. 2015. Delayed complications and long-term effects of SM poisonings: Experience of Iran-Iraq war. In: Balali-Mood M, Abdollahi M, editors. Basic and clinical toxicology of mustard compounds. New York (NY): Springer; p. 101–135.
   Google Scholar
• Das LM, Binko AM, Traylor ZP, Duesler L, Lu KQ. 2018. Defining the timing of 25(OH)D rescue following nitrogen mustard exposure. Cutan Ocul Toxicol. 37:127–132.
   PubMed Web of Science ®Google Scholar
• Das LM, Binko AM, Traylor ZP, Duesler LR, Dynda SM, Debanne S, Lu KQ. 2016. Early indicators of survival following exposure to mustard gas: Protective role of 25(OH)D. Toxicol Lett. 248:9–15.
   PubMed Web of Science ®Google Scholar
• Das SK, Mukherjee S, Smith MG, Chatterjee D. 2003. Prophylactic protection by N-acetylcysteine against the pulmonary injury induced by 2-chloroethyl ethyl sulfide, a mustard analogue. J Biochem Mol Toxicol. 17:177–184.
   PubMed Web of Science ®Google Scholar
• Davis KG, Aspera G. 2001. Exposure to liquid sulfur mustard. Ann Emerg Med. 37:653–656.
   PubMed Web of Science ®Google Scholar
• Dorr RT, Soble M, Alberts DS. 1988. Efficacy of sodium thiosulfate as a local antidote to mechlorethamine skin toxicity in the mouse. Cancer Chemother Pharmacol. 22:299–302.
   PubMed Web of Science ®Google Scholar
• Drugs.com. 2018. Available on https://www.drugs.com/mmx/sodium-thiosulfate.html at 1/10/2018.
   Google Scholar
• Dursun E, Gezen-Ak D, Yilmazer S. 2014. The influence of vitamin D treatment on the inducible nitric oxide synthase (INOS) expression in primary hippocampal neurons. Noro Psikiyatr Ars. 51:163–168.
   PubMedGoogle Scholar
• Eldad A, Weinberg A, Breiterman S, Chaouat M, Palanker D, Ben-Bassat H. 1998. Early nonsurgical removal of chemically injured tissue enhances wound healing in partial thickness burns. Burns. 24:166–172.
   PubMed Web of Science ®Google Scholar
• Etemad L, Moshiri M, Balali-Mood M. 2015. History of use and epidemiology of mustard compounds. In: Balali-Mood M, Abdollahi M, editors. Basic and clinical toxicology of mustard compounds. New York (NY): Springer; p. 29–49.
   Google Scholar
• Etemad L, Moshiri M, Balali-Mood M. 2018. Delayed Complications and Long-Term Management of Sulfur Mustard Poisoning: A Narrative Review of Recent Advances by Iranian Researchers PartII: Clinical Management and Therapy. Iran J Med Sci. 43:235–247.
   PubMed Web of Science ®Google Scholar
• Etezad-Razavi M, Mahmoudi M, Hefazi M, Balali-Mood M. 2006. Delayed ocular complications of mustard gas poisoning and the relationship with respiratory and cutaneous complications. Clin Experiment Ophthalmol. 34:342–346.
   PubMed Web of Science ®Google Scholar
• Evison D, Brown RF, Rice P. 2006. The treatment of sulphur mustard burns with laser debridement. J Plast Reconstr Aesthet Surg. 59:1087–1093.
   PubMed Web of Science ®Google Scholar
• Feister AJ. 1991. Medical defense against mustard gas: toxic mechanisms and pharmacological implications. Boston, CRC press.
   Google Scholar
• Freitag L, Firusian N, Stamatis G, Greschuchna D. 1991. The role of bronchoscopy in pulmonary complications due to mustard gas inhalation. Chest. 100:1436–1441.
   PubMed Web of Science ®Google Scholar
• Gao X, Anderson DR, Brown AW, Lin H, Amnuaysirikul J, Chua AL, Holmes WW, Ray P. 2011. Pathological studies on the protective effect of a macrolide antibiotic, roxithromycin, against sulfur mustard inhalation toxicity in a rat model. Toxicol Pathol. 39:1056–1064.
   PubMed Web of Science ®Google Scholar
• Gao X, Ray R, Xiao Y, Barker PE, Ray P. 2007. Inhibition of sulfur mustard-induced cytotoxicity and inflammation by the macrolide antibiotic roxithromycin in human respiratory epithelial cells. BMC Cell Biol. 8:17.
   PubMed Web of Science ®Google Scholar
• Gao X, Ray R, Xiao Y, Ishida K, Ray P. 2010. Macrolide antibiotics improve chemotactic and phagocytic capacity as well as reduce inflammation in sulfur mustard-exposed monocytes. Pulm Pharmacol Ther. 23:97–106.
   PubMed Web of Science ®Google Scholar
• Gautam A, Gupta A, Lomash V, Pant SC, Vijayaraghavan R. 2010. Prophylactic efficacy of combination of DRDE-07 and its analogues with amifostine against sulphur mustard induced systemic toxicity. Indian J Exp Biol. 48:752–761.
   PubMed Web of Science ®Google Scholar
• Ghanei M, Fathi H, Mohammad MM, Aslani J, Nematizadeh F. 2004. Long-term respiratory disorders of claimers with subclinical exposure to chemical warfare agents. Inhal Toxicol. 16:491–495.
   PubMed Web of Science ®Google Scholar
• Ghasemi H, Ghazanfari T, Ghassemi-Broumand M, Javadi MA, Babaei M, Soroush MR, Yaraee R, Faghihzadeh S, Poorfarzam S, Owlia P, et al. 2009. Long-term ocular consequences of sulfur mustard in seriously eye-injured war veterans. Cutan Ocul Toxicol. 28:71–77.
   PubMed Web of Science ®Google Scholar
• Ghasemi H, Ghazanfari T, Yaraee R, Soroush MR, Ghassemi-Broumand M, Poorfarzam S, Babaei M, Javadi MA, Owlia P, Amiri S, et al. 2009. Systemic and ocular complications of sulfur mustard: A panoramic review. Toxin Rev. 28:14–23.
   Web of Science ®Google Scholar
• Ghazanfari T, Faghihzadeh S, Aragizadeh H, Soroush MR, Yaraee R, Mohammad Hassan Z, Foroutan A, Vaez-Mahdavi MR, Javadi MA, Moaiedmohseni S, et al. 2009. Sardasht-Iran cohort study of chemical warfare victims: design and methods. Arch Iran Med. 12:5–14.
   PubMed Web of Science ®Google Scholar
• Gholami M, Moallem SA, Afshar M, Amoueian S, Etemad L, Karimi G. 2016. Teratogenic effects of silymarin on mouse fetuses. Avicenna J Phytomed. 6:542–549.
   PubMed Web of Science ®Google Scholar
• Gholamnezhad Z, Boskabady MH, Amery S, Vahedi N, Tabatabaei A, Boskabady M, Shahriary A. 2016. The effect of vitamin E on lung pathology in sulfur mustard-exposed guinea pigs. Toxicol Ind Health. 32:1971–1977.
   PubMed Web of Science ®Google Scholar
• Ghorani-Azam A, Balali-Mood M. 2015. Clinical pharmacology and toxicology of mustard compounds. In: Balali-Mood M, Abdollahi M, editors. Basic and clinical toxicology of mustard compounds. New York (NY): Springer; p. 63–101.
   Google Scholar
• Gold MB, Bongiovanni R, Scharf BA, Gresham VC, Woodward CL. 1994. Hypochlorite solution as a decontaminant in sulfur mustard contaminated skin defects in the euthymic hairless guinea pig. Drug Chem Toxicol. 17:499–527.
   PubMed Web of Science ®Google Scholar
• Gold MB, Scharf BA. 1995. Hematological profile of the euthymic hairless guinea pig following sulfur mustard vesicant exposure. J Appl Toxicol. 15:433–438.
   PubMed Web of Science ®Google Scholar
• Gonzalez GG, Gallar J, Belmonte C. 1995. Influence of diltiazem on the ocular irritative response to nitrogen mustard. Exp Eye Res. 61:205–212.
   PubMed Web of Science ®Google Scholar
• Gordon MK, Desantis A, Deshmukh M, Lacey CJ, Hahn RA, Beloni J, Anumolu SS, Schlager JJ, Gallo MA, Gerecke DR, et al. 2010. Doxycycline hydrogels as a potential therapy for ocular vesicant injury. J Ocul Pharmacol Ther. 26:407–419.
   PubMed Web of Science ®Google Scholar
• Gore A, Horwitz V, Cohen M, Gutman H, Cohen L, Gez R, Kadar T, Dachir S. 2018. Successful single treatment with ziv-aflibercept for existing corneal neovascularization following ocular chemical insult in the rabbit model. Exp Eye Res. 171:183–191.
   PubMed Web of Science ®Google Scholar
• Graham JS, Chilcott RP, Rice P, Milner SM, Hurst CG, Maliner BI. 2005. Wound healing of cutaneous sulfur mustard injuries: strategies for the development of improved therapies. J Burns Wounds. 4:e1.
   PubMedGoogle Scholar
• Graham JS, Schomacker KT, Glatter RD, Briscoe CM, Braue EH Jr, Squibb KS. 2002. Bioengineering methods employed in the study of wound healing of sulphur mustard burns. Skin Res Technol. 8:57–69.
   PubMed Web of Science ®Google Scholar
• Graham JS, Schomacker KT, Glatter RD, Briscoe CM, Braue EH, Jr, Squibb KS. 2002. Efficacy of laser debridement with autologous split-thickness skin grafting in promoting improved healing of deep cutaneous sulfur mustard burns. Burns. 28:719–730.
   PubMed Web of Science ®Google Scholar
• Graham JS, Schoneboom BA. 2013. Historical perspective on effects and treatment of sulfur mustard injuries. Chem Biol Interact. 206:512–522.
   PubMed Web of Science ®Google Scholar
• Graham JS, Stevenson RS, Mitcheltree LW, Hamilton TA, Deckert RR, Lee RB, Schiavetta AM. 2009. Medical management of cutaneous sulfur mustard injuries. Toxicology. 263:47–58.
   PubMed Web of Science ®Google Scholar
• Grando SA. 2003. Mucocutaneous cholinergic system is targeted in mustard-induced vesication. Life Sci. 72:2135–2144.
   PubMed Web of Science ®Google Scholar
• Gross CL, Innace JK, Hovatter RC, Meier HL, Smith WJ. 1993. Biochemical manipulation of intracellular glutathione levels influences cytotoxicity to isolated human lymphocytes by sulfur mustard. Cell Biol Toxicol. 9:259–267.
   PubMed Web of Science ®Google Scholar
• Gross CL, Nealley EW, Nipwoda MT, Smith WJ. 2006. Pretreatment of human epidermal keratinocytes with D,L-sulforaphane protects against sulfur mustard cytotoxicity. Cutan Ocul Toxicol. 25:155–163.
   PubMed Web of Science ®Google Scholar
• Gross CL, Nipwoda MT, Nealley EW, Smith WJ. 2004. Pretreatment of human epidermal keratinocytes in vitro with ethacrynic Acid reduces sulfur mustard cytotoxicity. Toxicol Mech Methods. 14:317–322.
   PubMed Web of Science ®Google Scholar
• Gu TY. 2014. Mechanism and treatment of sulfur mustard-induced cutaneous injury. Chin J Traumatol. 17:345–350.
   PubMedGoogle Scholar
• Guignabert C, Taysse L, Calvet JH, Planus E, Delamanche S, Galiacy S, d’Ortho MP. 2005. Effect of doxycycline on sulfur mustard-induced respiratory lesions in guinea pigs. Am J Physiol Lung Cell Mol Physiol. 289:L67–L74.
   PubMed Web of Science ®Google Scholar
• Hambrook JL, Harrison JM, Howells DJ, Schock C. 1992. Biological fate of sulphur mustard (1,1'-thio-bis(2-chloroethane)): urinary and faecal excretion of 35S by rat after injection or cutaneous application of 35S-labelled sulphur mustard. Xenobiotica. 22:65–75.
   PubMed Web of Science ®Google Scholar
• Hambrook JL, Howells DJ, Schock C. 1993. Biological fate of sulphur mustard (1,1'-thiobis(2-chloroethane)): uptake, distribution and retention of 35S in skin and in blood after cutaneous application of 35S-sulphur mustard in rat and comparison with human blood in vitro. Xenobiotica. 23:537–561.
   PubMed Web of Science ®Google Scholar
• Hamilton MG, Dorandeu FM, McCaffery M, Lundy PM, Sawyer TW. 1998. Modification of cytosolic free calcium concentrations in human keratinocytes after sulfur mustard exposure. Toxicol in Vitro. 12:365–372.
   PubMed Web of Science ®Google Scholar
• Han S, Espinoza LA, Liao H, Boulares AH, Smulson ME. 2004. Protection by antioxidants against toxicity and apoptosis induced by the sulphur mustard analog 2-chloroethylethyl sulphide (CEES) in Jurkat T cells and normal human lymphocytes. Br J Pharmacol. 141:795–802.
   PubMed Web of Science ®Google Scholar
• Hatiboglu I, Mihich E, Moore GE, Nichol CA. 1962. Use of sodium thiosulfate as a neutralizing agent during regional administration of nitrogen mustard: an experimental study. Ann Surg. 156:994.
   PubMed Web of Science ®Google Scholar
• Henemyre-Harris CL, Adkins AL, Chuang AH, Graham JS. 2008. Addition of epidermal growth factor improves the rate of sulfur mustard wound healing in an in vitro model. Eplasty. 8:e16.
   PubMedGoogle Scholar
• Herr C, Greulich T, Koczulla RA, Meyer S, Zakharkina T, Branscheidt M, Eschmann R, Bals R. 2011. The role of vitamin D in pulmonary disease: COPD, asthma, infection, and cancer. Respiratory Res. 12:31.
   PubMed Web of Science ®Google Scholar
• Hinshaw DB, Lodhi IJ, Hurley LL, Atkins KB, Dabrowska MI. 1999. Activation of poly [ADP-Ribose] polymerase in endothelial cells and keratinocytes: role in an in vitro model of sulfur mustard-mediated vesication. Toxicol Appl Pharmacol. 156:17–29.
   PubMed Web of Science ®Google Scholar
• Hoesel LM, Flierl MA, Niederbichler AD, Rittirsch D, McClintock SD, Reuben JS, Pianko MJ, Stone W, Yang H, Smith M, et al. 2008. Ability of antioxidant liposomes to prevent acute and progressive pulmonary injury. Antioxid Redox Signal. 10:973–981.
   PubMed Web of Science ®Google Scholar
• Horwitz V, Dachir S, Cohen M, Gutman H, Cohen L, Fishbine E, Brandeis R, Turetz J, Amir A, Gore A, et al. 2014. The beneficial effects of doxycycline, an inhibitor of matrix metalloproteinases, on sulfur mustard-induced ocular pathologies depend on the injury stage. Curr Eye Res. 39:803–812.
   PubMed Web of Science ®Google Scholar
• Horwitz V, Dachir S, Cohen M, Gutman H, Cohen L, Fishbine E, Brandeis R, Turetz J, Amir A, Gore A, et al. 2016. Re: the beneficial effects of doxycycline, an inhibitor of matrix metalloproteinases, on sulfur mustard-induced ocular pathologies depend on the injury stage. Curr Eye Res. 41:135–136.
   PubMed Web of Science ®Google Scholar
• Hossein BM, Nasim V, Sediqa A. 2008. The protective effect of Nigella sativa on lung injury of sulfur mustard-exposed Guinea pigs. Exp Lung Res. 34:183–194.
   PubMed Web of Science ®Google Scholar
• Imani S, Panahi Y, Salimian J, Fu J, Ghanei M. 2015. Epigenetic: A missing paradigm in cellular and molecular pathways of sulfur mustard lung: a prospective and comparative study. Iran J Basic Med Sci. 18:723–736.
   PubMed Web of Science ®Google Scholar
• Institute of Medicine. 1999. Chemical and biological terrorism: research and development to improve civilian medical response. Washington (DC): The National Academies Press.
   Google Scholar
• Ishida H, Ray R, Ray P. 2008. Sulfur mustard downregulates iNOS expression to inhibit wound healing in a human keratinocyte model. J Dermatol Sci.49:207–216.
   PubMed Web of Science ®Google Scholar
• Jain AK, Tewari-Singh N, Inturi S, Kumar D, Orlicky DJ, Agarwal C, White CW, Agarwal R. 2015. Flavanone silibinin treatment attenuates nitrogen mustard-induced toxic effects in mouse skin. Toxicol Appl Pharmacol. 285:71–78.
   PubMed Web of Science ®Google Scholar
• Jain AK, Tewari-Singh N, Inturi S, Orlicky DJ, White CW, Agarwal R. 2014. Myeloperoxidase deficiency attenuates nitrogen mustard-induced skin injuries. Toxicology. 320:25–33.
   PubMed Web of Science ®Google Scholar
• Joseph LB, Gerecke DR, Heck DE, Black AT, Sinko PJ, Cervelli JA, Casillas RP, Babin MC, Laskin DL, Laskin JD. 2011. Structural changes in the skin of hairless mice following exposure to sulfur mustard correlate with inflammation and DNA damage. Exp Mol Pathol. 91:515–527.
   PubMed Web of Science ®Google Scholar
• Jost P, Fikrova P, Svobodova H, Pejchal J, Stetina R. 2017. Protective potential of different compounds and their combinations with MESNA against sulfur mustard-induced cytotoxicity and genotoxicity. Toxicol Lett. 275:92–100.
   PubMed Web of Science ®Google Scholar
• Jugg B, Fairhall S, Smith A, Rutter S, Mann T, Perrott R, Jenner J, Salguero J, Shute J, Sciuto AM. 2013. N-acetyl-L-cysteine protects against inhaled sulfur mustard poisoning in the large swine. Clin Toxicol (Phila). 51:216–224.
   PubMed Web of Science ®Google Scholar
• Jung H, Kah D, Chan Lim K, Lee JY. 2017. Fate of sulfur mustard on soil: evaporation, degradation, and vapor emission. Environ Pollut. 220:478–486.
   PubMed Web of Science ®Google Scholar
• Kadar T, Amir A, Cohen L, Cohen M, Sahar R, Gutman H, Horwitz V, Dachir S. 2014. Anti-VEGF therapy (bevacizumab) for sulfur mustard-induced corneal neovascularization associated with delayed limbal stem cell deficiency in rabbits. Curr Eye Res. 39:439–450.
   PubMed Web of Science ®Google Scholar
• Kadar T, Dachir S, Cohen L, Sahar R, Fishbine E, Cohen M, Turetz J, Gutman H, Buch H, Brandeis R, et al. 2009. Ocular injuries following sulfur mustard exposure-pathological mechanism and potential therapy. Toxicology. 263:59–69.
   PubMed Web of Science ®Google Scholar
• Kadar T, Dachir S, Cohen M, Gutman H, Cohen L, Brandeis R, Horwitz V, Amir A. 2013. Prolonged impairment of corneal innervation after exposure to sulfur mustard and its relation to the development of delayed limbal stem cell deficiency. Cornea. 32:e44–e50.
   PubMed Web of Science ®Google Scholar
• Kadar T, Fishbeine E, Meshulam Y, Sahar R, Chapman S, Liani H, Barness I, Amir A. 2000. Treatment of skin injuries induced by sulfur mustard with calmodulin antagonists, using the pig model. J Appl Toxicol. 20: S133–S136.
   PubMedGoogle Scholar
• Kaler A, Mittal AK, Katariya M, Harde H, Agrawal AK, Jain S, Banerjee UC. 2014. An investigation of in vivo wound healing activity of biologically synthesized silver nanoparticles [journal article]. J Nanoparticle Res. 16:2605.
   Web of Science ®Google Scholar
• Karimi G, Vahabzadeh M, Lari P, Rashedinia M, Moshiri M. 2011. “Silymarin”, a promising pharmacological agent for treatment of diseases. Iran J Basic Med Sci. 14:308–317.
   PubMed Web of Science ®Google Scholar
• Kehe K, Balszuweit F, Emmler J, Kreppel H, Jochum M, Thiermann H. 2008. Sulfur mustard research-strategies for the development of improved medical therapy. Eplasty. 8:e32.
   PubMedGoogle Scholar
• Kehe K, Balszuweit F, Steinritz D, Thiermann H. 2009. Molecular toxicology of sulfur mustard-induced cutaneous inflammation and blistering. Toxicology. 263:12–19.
   PubMed Web of Science ®Google Scholar
• Kehe K, Raithel K, Kreppel H, Jochum M, Worek F, Thiermann H. 2008. Inhibition of poly(ADP-ribose) polymerase (PARP) influences the mode of sulfur mustard (SM)-induced cell death in HaCaT cells. Arch Toxicol. 82:461–470.
   PubMed Web of Science ®Google Scholar
• Kehe K, Szinicz L. 2005. Medical aspects of sulphur mustard poisoning. Toxicology. 214:198–209.
   PubMed Web of Science ®Google Scholar
• Kehe K, Thiermann H, Balszuweit F, Eyer F, Steinritz D, Zilker T. 2009. Acute effects of sulfur mustard injury-Munich experiences. Toxicology. 263:3–8.
   PubMed Web of Science ®Google Scholar
• Keyser B, Andres D, Benton B, Ray R. 2008. Fas targeted siRNA markedly attenuates sulfur mustard-induced apoptosis in human airway epithelial cells. The FASEB J. 22:1140–1141.
   Web of Science ®Google Scholar
• Kiani A, Mostafaie A, Shirazi FH, Ghazanfari T. 2013. Serum profiles of matrix metalloproteinases and their tissue inhibitors in long-term pulmonary complication induced by sulfur mustard: Sardasht-Iran Cohort Study (SICS). Int Immunopharmacol. 17:964–967.
   PubMed Web of Science ®Google Scholar
• Kindred JE. 1947. Histologic changes occurring in the hemopoietic organs of albino rats after single injections of 2-chloroethyl vesicants; a quantitative study. Arch Pathol (Chic). 43:253.
   PubMedGoogle Scholar
• Kjellstrom BT, Persson JK, Runn P. 1997. Surgical treatment of skin lesions induced by sulfur mustard (mustard gas)-an experimental study in the guinea pig. Ann Acad Med Singap. 26:30–36.
   PubMedGoogle Scholar
• Korkmaz A, Yaren H, Kunak ZI, Uysal B, Kurt B, Topal T, Kenar L, Ucar E, Oter S. 2008. Epigenetic perturbations in the pathogenesis of mustard toxicity; hypothesis and preliminary results. Interdiscip Toxicol. 1:236–241.
   PubMedGoogle Scholar
• Kouvaris JR, Kouloulias VE, Vlahos LJ. 2007. Amifostine: the first selective-target and broad-spectrum radioprotector. Oncologist. 12:738–747.
   PubMed Web of Science ®Google Scholar
• Kuderer NM, Dale DC, Crawford J, Lyman GH. 2007. Impact of primary prophylaxis with granulocyte colony-stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy: a systematic review. J Clin Oncol. 25:3158–3167.
   PubMed Web of Science ®Google Scholar
• Kulkarni AS, Vijayaraghavan R, Anshoo G, Satish HT, Pathak U, Raza SK, Pant SC, Malhotra RC, Prakash AO. 2006. Evaluation of analogues of DRDE-07 as prophylactic agents against the lethality and toxicity of sulfur mustard administered through percutaneous route. J Appl Toxicol. 26:115–125.
   PubMed Web of Science ®Google Scholar
• Kumar D, Tewari-Singh N, Agarwal C, Jain AK, Inturi S, Kant R, White CW, Agarwal R. 2015. Nitrogen mustard exposure of murine skin induces DNA damage, oxidative stress and activation of MAPK/Akt-AP1 pathway leading to induction of inflammatory and proteolytic mediators. Toxicol Lett. 235:161–171.
   PubMed Web of Science ®Google Scholar
• Kumar O, Sugendran K, Vijayaraghavan R. 2001. Protective effect of various antioxidants on the toxicity of sulphur mustard administered to mice by inhalation or percutaneous routes. Chem Biol Interact. 134:1–12.
   PubMed Web of Science ®Google Scholar
• Kumar P, Gautam A, Prakash CJ, Kumar A, Ganeshan K, Pathak U, Vijayaraghavan R. 2010. Ameliorative effect of DRDE 07 and its analogues on the systemic toxicity of sulphur mustard and nitrogen mustard in rabbit. Hum Exp Toxicol. 29:747–755.
   PubMed Web of Science ®Google Scholar
• Kumar P, Vijayaraghavan R, Kulkarni AS, Pathak U, Raza SK, Jaiswal DK. 2002. In vivo protection by amifostine and DRDE-07 against sulphur mustard toxicity. Hum Exp Toxicol. 21:371–376.
   PubMed Web of Science ®Google Scholar
• Kuo YT, Kuo CH, Lam KP, Chu YT, Wang WL, Huang CH, Hung CH. 2010. Effects of vitamin D3 on expression of tumor necrosis factor-alpha and chemokines by monocytes. J Food Sci. 75:H200.
   PubMed Web of Science ®Google Scholar
• Langford AM, Hobbs MJ, Upshall DG, Blain PG, Williams FM. 1996. The effect of sulphur mustard on glutathione levels in rat lung slices and the influence of treatment with arylthiols and cysteine esters. Hum Exp Toxicol. 15:619–624.
   PubMed Web of Science ®Google Scholar
• Layegh P, Maleki M, Mousavi SR, Yousefzadeh H, Momenzadeh A, Golmohammadzadeh S, Balali-Mood M. 2015. Epidermal hydration and skin surface lipids in patients with long-term complications of sulfur mustard poisoning. J Res Med Sci. 20:640–645.
   PubMed Web of Science ®Google Scholar
• Lee JH, Kagan E. 2014. Role of nicotinamide adenine dinucleotide phosphate oxidase in mediating vesicant-induced interleukin-6 secretion in human airway epithelial cells. Am J Respir Cell Mol Biol. 50:713–722.
   PubMed Web of Science ®Google Scholar
• Lindsay CD, Gentilhomme E, Mathieu JD. 2008. The use of doxycycline as a protectant against sulphur mustard in HaCaT cells. J Appl Toxicol. 28:665–673.
   PubMed Web of Science ®Google Scholar
• Lindsay CD, Hambrook JL, Lailey AF. 1997. Monoisopropylglutathione ester protects A549 cells from the cytotoxic effects of sulphur mustard. Hum Exp Toxicol. 16:636–644.
   PubMed Web of Science ®Google Scholar
• Liu DK, Wannemacher RW, Snider TH, Hayes TL. 1999. Efficacy of the topical skin protectant in advanced development. J Appl Toxicol. 19 Suppl 1:S40–S45.
   PubMed Web of Science ®Google Scholar
• Liu J, Zhong X, He Z, Wei L, Zheng X, Zhang J, Bai J, Zhong W, Zhong D. 2014. Effect of low-dose, long-term roxithromycin on airway inflammation and remodeling of stable noncystic fibrosis bronchiectasis. Mediators Inflamm. 2014:708608.
   PubMedGoogle Scholar
• Maisonneuve A, Callebat I, Debordes L, Coppet L. 1993. Biological fate of sulphur mustard in rat: toxicokinetics and disposition. Xenobiotica. 23:771–780.
   PubMed Web of Science ®Google Scholar
• Mak IT, Weglicki WB. 1990. Comparative antioxidant activities of propranolol, nifedipine, verapamil, and diltiazem against sarcolemmal membrane lipid peroxidation. Circ Res. 66:1449–1452.
   PubMed Web of Science ®Google Scholar
• Malaviya R, Sunil VR, Cervelli J, Anderson DR, Holmes WW, Conti ML, Gordon RE, Laskin JD, Laskin DL. 2010. Inflammatory effects of inhaled sulfur mustard in rat lung. Toxicol Appl Pharmacol. 248:89–99.
   PubMed Web of Science ®Google Scholar
• Malaviya R, Sunil VR, Venosa A, Vayas KN, Heck DE, Laskin JD, Laskin DL. 2016. Inflammatory mechanisms of pulmonary injury induced by mustards. Toxicol Lett. 244:2–7.
   PubMed Web of Science ®Google Scholar
• Malhotra R, Ganesan K, Sugendran K, Swamy R. 2013. Chemistry and toxicology of sulphur mustard-a review. Dsj. 49:97–116.
   Google Scholar
• Margulis A, Chaouat M, Ben-Bassat H, Eldad A, Icekson M, Breiterman S, Neuman R. 2007. Comparison of topical iodine and silver sulfadiazine as therapies against sulfur mustard burns in a pig model. Wound Repair Regen. 15:916–921.
   PubMed Web of Science ®Google Scholar
• Mazumder PK, Sugendran K, Vijayaraghavan R. 1998. Protective efficacy of calcium channel blockers in sulphur mustard poisoning. Biomed Environ Sci. 11:363–369.
   PubMed Web of Science ®Google Scholar
• McClintock SD, Hoesel LM, Das SK, Till GO, Neff T, Kunkel RG, Smith MG, Ward PA. 2006. Attenuation of half sulfur mustard gas-induced acute lung injury in rats. J Appl Toxicol. 26:126–131.
   PubMed Web of Science ®Google Scholar
• McGraw MD, Osborne CM, Mastej EJ, Di Paola JA, Anderson DR, Holmes WW, Paradiso DC, Garlick RB, Hendry-Hofer TB, Rancourt RC, et al. 2017. Editor's highlight: pulmonary vascular thrombosis in rats exposed to inhaled sulfur mustard. Toxicol Sci. 159:461–469.
   PubMed Web of Science ®Google Scholar
• McKinley MD, McKinley FR, McGown EL. 1982. Thiosulfate as an Antidote to Mustard Poisoning, A Review of the Literature. Letterman Army Institute of Research Presidio of San Francisco Ca.
   Google Scholar
• McManus J, Huebner K. 2005. Vesicants. Crit Care Clin. 21:707vi.
   PubMed Web of Science ®Google Scholar
• McNutt P, Lyman M, Swartz A, Tuznik K, Kniffin D, Whitten K, Milhorn D, Hamilton T. 2012. Architectural and biochemical expressions of mustard gas keratopathy: preclinical indicators and pathogenic mechanisms. PLoS One. 7:e42837.
   PubMed Web of Science ®Google Scholar
• Meckler G, Quereshi N, Al-Mogbil M, Kentab O. 2016. Tintinalli's emergency medicine: a comprehensive study guide. New York (NY): McGraw-Hill.
   Google Scholar
• Meisenberg BR, Melaragno AJ, Monroy RL. 1993. Granulocyte colony stimulating factor (G-CSF) for mustard-induced bone marrow suppression. Mil Med. 158:470–474.
   PubMed Web of Science ®Google Scholar
• Mellor SG, Rice P, Cooper GJ. 1991. Vesicant burns. Br J Plast Surg. 44:434–437.
   PubMedGoogle Scholar
• Menacher G, Steinritz D, Schmidt A, Popp T, Worek F, Gudermann T, Thiermann H, Balszuweit F. 2018. Effects of anti-inflammatory compounds on sulfur mustard injured cells: Recommendations and caveats suggested by in vitro cell culture models. Toxicol Lett. 293:91–97.
   PubMed Web of Science ®Google Scholar
• Merz D, AndersonD. 2001. Cytoprotective effect of mesna treatment for sulfur mustard (HD) induced lung injury. FASEB Journal; 2001: Federation AMER SOC EXP BIOL 9650 Rockville Pike, Bethesda, MD 20814-3998 USA.
   Google Scholar
• Mi L, Gong W, Nelson P, Martin L, Sawyer TW. 2003. Hypothermia reduces sulphur mustard toxicity. Toxicol Appl Pharmacol. 193:73–83.
   PubMed Web of Science ®Google Scholar
• Milosavljevic Z. 1985. [Treatment of general toxic lesions caused by sulfur and nitrogen mustard in rats]. God Vojnomed Akad. 27:79–82.
   PubMedGoogle Scholar
• Mizrahi DM, Goldvaser M, Columbus I. 2011. Long-term evaluation of the fate of sulfur mustard on dry and humid soils, asphalt, and concrete. Environ Sci Technol. 45:3466–3472.
   PubMed Web of Science ®Google Scholar
• Mol MA, Smith WJ. 1996. Ca2+ homeostasis and Ca2+ signalling in sulphur mustard-exposed normal human epidermal keratinocytes. Chem Biol Interact. 100:85–93.
   PubMed Web of Science ®Google Scholar
• Mol ME, de Vries R, Kluivers AW. 1991. Effects of nicotinamide on biochemical changes and microblistering induced by sulfur mustard in human skin organ cultures. Toxicol Appl Pharmacol. 107:439–449.
   PubMed Web of Science ®Google Scholar
• Momeni AZ, Enshaeih S, Meghdadi M, Amindjavaheri M. 1992. Skin manifestations of mustard gas. A clinical study of 535 patients exposed to mustard gas. Arch Dermatol. 128:775–780.
   PubMed Web of Science ®Google Scholar
• Moser J, Levine CF, Thomas-Dunmeyer DR, Smith WJ. 2004. Cross-linking interferes with assessing sulfur mustard-induced DNA damage in human peripheral blood lymphocytes using the comet assay. Toxicol Mech Methods. 14:195–202.
   PubMed Web of Science ®Google Scholar
• Mouret S, Wartelle J, Batal M, Emorine S, Bertoni M, Poyot T, Clery-Barraud C, Bakdouri NE, Peinnequin A, Douki T, et al. 2015. Time course of skin features and inflammatory biomarkers after liquid sulfur mustard exposure in SKH-1 hairless mice. Toxicol Lett. 232:68–78.
   PubMed Web of Science ®Google Scholar
• National Institute for Occupational Safety and Health (NIOSH). 2015. Sulfur Mustard: Blister Agent, Available at:https://www.cdc.gov/niosh/ershdb/emergencyresponsecard_29750008.html. Acceesed 3/5/2017. Centers for Disease Control and Prevention.; [accessed].
   Google Scholar
• Ng ET, Sim MK, Loke WK. 2011. Protective actions of des-aspartate-angiotensin I in mice model of CEES-induced lung intoxication. J Appl Toxicol. 31:568–578.
   PubMed Web of Science ®Google Scholar
• Noort D, Hulst AG, de Jong LP, Benschop HP. 1999. Alkylation of human serum albumin by sulfur mustard in vitro and in vivo: mass spectrometric analysis of a cysteine adduct as a sensitive biomarker of exposure. Chem Res Toxicol. 12:715–721.
   PubMed Web of Science ®Google Scholar
• Nourani MR, Mahmoodzadeh Hosseini H, Azimzadeh Jamalkandi S, Imani Fooladi AA. 2017. Cellular and molecular mechanisms of acute exposure to sulfur mustard: a systematic review. J Recept Signal Transduct Res. 37:200–216.
   PubMed Web of Science ®Google Scholar
• Nyska A, Lomnitski L, Maronpot R, Moomaw C, Brodsky B, Sintov A, Wormser U. 2001. Effects of iodine on inducible nitric oxide synthase and cyclooxygenase-2 expression in sulfur mustard-induced skin. Arch Toxicol. 74:768–774.
   PubMed Web of Science ®Google Scholar
• O’Neill HC, White CW, Veress LA, Hendry-Hofer TB, Loader JE, Min E, Huang J, Rancourt RC, Day BJ. 2010. Treatment with the catalytic metalloporphyrin AEOL 10150 reduces inflammation and oxidative stress due to inhalation of the sulfur mustard analog 2-chloroethyl ethyl sulfide. Free Radic Biol Med. 48:1188–1196.
   PubMed Web of Science ®Google Scholar
• Orozco-Peláez YA. 2018. Airway burn or inhalation injury: should all patients be intubated?. Revista Colombiana de Anestesiología. 46:26–31.
   Google Scholar
• Paromov V, Brannon M, Kumari S, Samala M, Qui M, Smith M, Stone WL. 2011a. Sodium pyruvate modulates cell death pathways in HaCaT keratinocytes exposed to half-mustard gas. Int J Toxicol. 30:197–206.
   PubMed Web of Science ®Google Scholar
• Paromov V, Kumari S, Brannon M, Kanaparthy NS, Yang H, Smith MG, Stone WL. 2011b. Protective effect of liposome-encapsulated glutathione in a human epidermal model exposed to a mustard gas analog. J Toxicol. 2011:1.
   Google Scholar
• Paromov V, Qui M, Yang H, Smith M, Stone WL. 2008. The influence of N-acetyl-L-cysteine on oxidative stress and nitric oxide synthesis in stimulated macrophages treated with a mustard gas analogue. BMC Cell Biol. 9:33.
   PubMed Web of Science ®Google Scholar
• Petrali JP, Oglesby SB, Meier HL. 1990. Ultrastructural correlates of the protection afforded by niacinamide against sulfur mustard-induced cytotoxicity of human lymphocytes in vitro. Ultrastruct Pathol. 14:253–262.
   PubMed Web of Science ®Google Scholar
• Pino MA, Billack B. 2008. Reduction of vesicant toxicity by butylated hydroxyanisole in A-431 skin cells. Cutan Ocul Toxicol. 27:161–172.
   PubMed Web of Science ®Google Scholar
• Plahovinsak JL, Buccellato MA, Reid FM, Graham JS. 2016. Selection of non-steroidal anti-inflammatory drug and treatment regimen for sulfur mustard-induced cutaneous lesions. Cutan Ocul Toxicol. 35:208–217.
   PubMed Web of Science ®Google Scholar
• Pohanish RP. 2004. Hazmat data: for first response, transportation, storage, and security. 2nd ed. London (UK): Wiley-Interscience.
   Google Scholar
• Poursaleh Z, Harandi AA, Vahedi E, Ghanei M. 2012. Treatment for sulfur mustard lung injuries; new therapeutic approaches from acute to chronic phase. Daru. 20:27.
   PubMed Web of Science ®Google Scholar
• Public Health Emergency. 2018. BARDA evaluates burn dressing for radiation, sulfur mustard burns. Available on:https://www.phe.gov/Preparedness/mcm/Pages/silverion.aspx. available at 9/10/2018. avail; [accessed].
   Google Scholar
• Rappeneau S, Baeza-Squiban A, Marano F, Calvet J. 2000. Efficient protection of human bronchial epithelial cells against sulfur and nitrogen mustard cytotoxicity using drug combinations. Toxicol Sci. 58:153–160.
   PubMed Web of Science ®Google Scholar
• Ray R, Keyser B, Benton B, Daher A, Simbulan-Rosenthal CM, Rosenthal DS. 2008. Sulfur mustard induces apoptosis in cultured normal human airway epithelial cells: evidence of a dominant caspase-8-mediated pathway and differential cellular responses. Drug Chem Toxicol. 31:137–148.
   PubMed Web of Science ®Google Scholar
• Ray R, Legere RH, Majerus BJ, Petrali JP. 1995. Sulfur mustard-induced increase in intracellular free calcium level and arachidonic acid release from cell membrane. Toxicol Appl Pharmacol. 131:44–52.
   PubMed Web of Science ®Google Scholar
• Ray R, Simbulan-Rosenthal CM, Keyser BM, Benton B, Anderson D, Holmes W, Trabosh VA, Daher A, Rosenthal DS. 2010. Sulfur mustard induces apoptosis in lung epithelial cells via a caspase amplification loop. Toxicology. 271:94–99.
   PubMed Web of Science ®Google Scholar
• Razavi MS, Salamati P, Saghafinia M, Abdollahi M. 2012. A review on delayed toxic effects of sulfur mustard in Iranian veterans. DARU Sci. 20:51.
   PubMed Web of Science ®Google Scholar
• Razavi SM, Salamati P, Harandi AA, Ghanei M. 2013. Prevention and treatment of respiratory consequences induced by sulfur mustard in Iranian casualties. Int J Prev Med. 4:383–389.
   PubMedGoogle Scholar
• Rejaei M, Rejaei P, Balali-Mood M. 2010. Nursing care of acute sulfur mustard poisoning. Int J Occup Environ Med. 1:95–98.
   PubMedGoogle Scholar
• Riahi-Zanjani B, Balali-Mood M, Mousavi SR, Karimi G, Sadeghi M, Shirmast E, Mahmoudi M. 2014. Serum cytokine profiles of Khorasan veterans 23 years after sulfur mustard exposure. Cytokine. 70:161–164.
   PubMed Web of Science ®Google Scholar
• Rice P. 2003. Sulphur mustard injuries of the skin. Pathophysiology and management. Toxicol Rev. 22:111–118.
   PubMedGoogle Scholar
• Rice P, Brown RF, Lam DG, Chilcott RP, Bennett NJ. 2000. Dermabrasion-a novel concept in the surgical management of sulphur mustard injuries. Burns. 26:34–40.
   PubMed Web of Science ®Google Scholar
• Ries C, Popp T, Egea V, Kehe K, Jochum M. 2009. Matrix metalloproteinase-9 expression and release from skin fibroblasts interacting with keratinocytes: Upregulation in response to sulphur mustard. Toxicology. 263:26–31.
   PubMed Web of Science ®Google Scholar
• Romano JA, Jr, King JM. 2001. Psychological casualties resulting from chemical and biological weapons. Mil Med. 166:21–22.
   PubMedGoogle Scholar
• Rosenthal DS, Simbulan-Rosenthal CM, Iyer S, Smith WJ, Ray R, Smulson ME. 2000. Calmodulin, poly(ADP-ribose)polymerase and p53 are targets for modulating the effects of sulfur mustard. J Appl Toxicol. 20 Suppl 1:S43.
   PubMedGoogle Scholar
• Roshan Zamir T, Alavi SA, Ghassami F, Mirkheshti N, Ansari L. 2011. The therapeutic effect of colchicine on delayed pulmonary injury of sulfur mustard in animal model. J Isfahan Medical School. 28:1765–1773. in persion).
   Google Scholar
• RSDL. 2017. About RSDL. Avaiailable at: http://www.rsdl.com/skin-decontamination/rsdl/, Accessed: 01/07/2017.
   Google Scholar
• Ruff AL, Dillman JF. 2007. Signaling molecules in sulfur mustard-induced cutaneous injury. Eplasty. 8:e2.
   PubMedGoogle Scholar
• Saberi M, Zaree Mahmodabady A. 2009. The protective effects of N-Acetl-cysteine, oxo-thiazolidine-carboxylate, acetaminophen and their combinations against sulfur mustard cytotoxicity on human skin fibroblast cell line (HF2FF). Iran Biomed J. 13:215–221.
   PubMedGoogle Scholar
• Sadeghi M, Balali-Mood B. 2015. Chemistry of mustard compounds. In: Balali-Mood M, Abdollahi M, editors. Basic and clinical toxicology of mustard compounds. New York (NY): Springer; p. 1–29.
   Google Scholar
• Safarinejad MR, Moosavi SA, Montazeri B. 2001. Ocular injuries caused by mustard gas: diagnosis, treatment, and medical defense. Mil Med. 166:67–70.
   PubMed Web of Science ®Google Scholar
• Saladi RN, Smith E, Persaud AN. 2006. Mustard: a potential agent of chemical warfare and terrorism. Clin Exp Dermatol. 31:1–5.
   PubMed Web of Science ®Google Scholar
• Sawyer TW. 1998. Characterization of the protective effects of L-nitroarginine methyl ester (L-NAME) against the toxicity of sulphur mustard in vitro. Toxicology. 131:21–32.
   PubMed Web of Science ®Google Scholar
• Sawyer TW, Hamilton MG. 2000. Effect of intracellular calcium modulation on sulfur mustard cytotoxicity in cultured human neonatal keratinocytes. Toxicol in Vitro. 14:149–157.
   PubMed Web of Science ®Google Scholar
• Sawyer TW, Nelson P. 2008. Hypothermia as an adjunct therapy to vesicant-induced skin injury. Eplasty. 8:e25.
   PubMedGoogle Scholar
• Schapochnik A, da Silva MR, Leal MP, Esteves J, Hebeda CB, Sandri S, de Fatima Teixeira da Silva D, Farsky SHP, Marcos RL, Lino-Dos-Santos-Franco A. 2018. Vitamin D treatment abrogates the inflammatory response in paraquat-induced lung fibrosis. Toxicol Appl Pharmacol. 355:60–67.
   PubMed Web of Science ®Google Scholar
• Settle JAD. 1996. Principals of replacement fluid therapy. In: Settle JAD, editor. Principles and practice of burns management. New York (NY): Churchill Livingstone; p. 83–94.
   Google Scholar
• Shakarjian MP, Bhatt P, Gordon MK, Chang YC, Casbohm SL, Rudge TL, Kiser RC, Sabourin CL, Casillas RP, Ohman-Strickland P, et al. 2006. Preferential expression of matrix metalloproteinase-9 in mouse skin after sulfur mustard exposure. J Appl Toxicol. 26:239–246.
   PubMed Web of Science ®Google Scholar
• Sharma M, Vijayaraghavan R, Agrawal OP. 2010. Comparative toxic effect of nitrogen mustards (HN-1, HN-2, and HN-3) and sulfur mustard on hematological and biochemical variables and their protection by DRDE-07 and its analogues. Int J Toxicol. 29:391–401.
   PubMed Web of Science ®Google Scholar
• Shoeibi N, Abrishami M, Eslampoor A. 2015. Ocular injury by mustard gas;early and late complications. In: Balali-Mood M, Abdollahi M, editors. Basic and clinical toxicology of mustard compounds. New York (NY): Springer; p. 253–273.
   Google Scholar
• Shoeibi N, Mousavi MN, Balali-Mood M, Moshiri M, Darchini-Maragheh E, Mousavi SR, Abrishami M. 2017. Long-term complications of sulfur mustard poisoning: retinal electrophysiological assessment in 40 severely intoxicated Iranian veterans. Int J Retina Vitreous. 3:7.
   PubMedGoogle Scholar
• Shohrati M, Aslani J, Eshraghi M, Alaedini F, Ghanei M. 2008. Therapeutics effect of N-acetyl cysteine on mustard gas exposed patients: evaluating clinical aspect in patients with impaired pulmonary function test. Respir Med. 102:443–448.
   PubMed Web of Science ®Google Scholar
• Shohrati M, Haji Hosseini R, Esfandiari MA, Najafian N, Najafian B, Golbedagh A. 2014. Serum matrix metalloproteinase levels in patients exposed to sulfur mustard. Iran Red Crescent Med. J. 16:e15129.
   PubMed Web of Science ®Google Scholar
• Shohrati M, Karimzadeh I, Saburi A, Khalili H, Ghanei M. 2014. The role of N-acetylcysteine in the management of acute and chronic pulmonary complications of sulfur mustard: a literature review. Inhal Toxicol. 26:507–523.
   PubMed Web of Science ®Google Scholar
• Sidell FR, Takafuji ET, Franz DR. 1997. Medical aspects of chemical and biological warfare. Washington, DC. DTIC Document: Borden Institute.
   Google Scholar
• Simbulan-Rosenthal CM, Ray R, Benton B, Soeda E, Daher A, Anderson D, Smith WJ, Rosenthal DS. 2006. Calmodulin mediates sulfur mustard toxicity in human keratinocytes. Toxicology. 227:21–35.
   PubMed Web of Science ®Google Scholar
• Smith CN, Lindsay CD, Upshall DG. 1997. Presence of methenamine/glutathione mixtures reduces the cytotoxic effect of sulphur mustard on cultured SVK-14 human keratinocytes in vitro. Hum Exp Toxicol. 16:247–253.
   PubMed Web of Science ®Google Scholar
• Smith KJ, Graham JS, Hamilton TA, Skelton HG, Petrali JP, Hurst CG. 1997. Immunohistochemical studies of basement membrane proteins and proliferation and apoptosis markers in sulfur mustard induced cutaneous lesions in weanling pigs. J Dermatol Sci. 15:173–182.
   PubMed Web of Science ®Google Scholar
• Smith WJ. 2009. Therapeutic options to treat sulfur mustard poisoning-the road ahead. Toxicology. 263:70–73.
   PubMed Web of Science ®Google Scholar
• Solberg Y, Alcalay M, Belkin M. 1997. Ocular injury by mustard gas. Surv Ophthalmol. 41:461–466.
   PubMed Web of Science ®Google Scholar
• Spiandore M, Piram A, Lacoste A, Prevost P, Maloni P, Torre F, Asia L, Josse D, Doumenq P. 2017. Efficacy of scalp hair decontamination following exposure to vapours of sulphur mustard simulants 2-chloroethyl ethyl sulphide and methyl salicylate. Chem Biol Interact. 267:74–79.
   PubMed Web of Science ®Google Scholar
• Steinritz D, Bolck B, Schwarz J, Balszuweit F, Duhr S, Ibrahim M, Bloch W, Thiermann H, Kehe K. 2010. Effect of N-acetyl cysteine and alpha-linolenic acid on sulfur mustard caused impairment of in vitro endothelial tube formation. Toxicol Sci. 118:521–529.
   PubMed Web of Science ®Google Scholar
• Steinritz D, Schmidt A, Simons T, Ibrahim M, Morguet C, Balszuweit F, Thiermann H, Kehe K, Bloch W, Bolck B. 2014. Chlorambucil (nitrogen mustard) induced impairment of early vascular endothelial cell migration - effects of α-linolenic acid and N-acetylcysteine . Chem Biol Interact. 219:143–150.
   PubMed Web of Science ®Google Scholar
• Stenger B, Popp T, John H, Siegert M, Tsoutsoulopoulos A, Schmidt A, Muckter H, Gudermann T, Thiermann H, Steinritz D. 2017. N-Acetyl-L-cysteine inhibits sulfur mustard-induced and TRPA1-dependent calcium influx. Arch Toxicol. 91:2179–2189.
   PubMed Web of Science ®Google Scholar
• Sugendran K, Jeevaratnam K, Vijayaraghavan R, Das Gupta S. 1994. Therapeutic efficacy of saline and glucose saline against dermally applied sulphur mustard intoxication in mice. Dsj. 44:21–23.
   Google Scholar
• Sugendran K, Kumar P, Vijayaraghavan R. 1998. Treatment for sulphur mustard poisoning -a review. DSJ. 48:155–162.
   Google Scholar
• Sunil VR, Shen J, Patel-Vayas K, Gow AJ, Laskin JD, Laskin DL. 2012. Role of reactive nitrogen species generated via inducible nitric oxide synthase in vesicant-induced lung injury, inflammation and altered lung functioning. Toxicol Appl Pharmacol. 261:22–30.
   PubMed Web of Science ®Google Scholar
• Tabarestani M, Balau-Mood M, Farhoodi M. 1990. Hematological findings of sulphur mustard poisoning in Iranian combatants. Med J Islamic Republic Iran (MJIRI) 4:185–190.
   Google Scholar
• Taysse L, Daulon S, Delamanche S, Bellier B, Breton P. 2007. Skin decontamination of mustards and organophosphates: comparative efficiency of RSDL and Fuller's earth in domestic swine. Hum Exp Toxicol. 26:135–141.
   PubMed Web of Science ®Google Scholar
• Tewari-Singh N, Agarwal C, Huang J, Day BJ, White CW, Agarwal R. 2011. Efficacy of glutathione in ameliorating sulfur mustard analog-induced toxicity in cultured skin epidermal cells and in SKH-1 mouse skin in vivo. J Pharmacol Exp Ther. 336:450–459.
   PubMed Web of Science ®Google Scholar
• Tewari-Singh N, Jain AK, Inturi S, Ammar DA, Agarwal C, Tyagi P, Kompella UB, Enzenauer RW, Petrash JM, Agarwal R. 2012. Silibinin, dexamethasone, and doxycycline as potential therapeutic agents for treating vesicant-inflicted ocular injuries. Toxicol Appl Pharmacol. 264:23–31.
   PubMed Web of Science ®Google Scholar
• Thiermann H, Worek F, Kehe K. 2013. Limitations and challenges in treatment of acute chemical warfare agent poisoning. Chem Biol Interact. 206:435–443.
   PubMed Web of Science ®Google Scholar
• Toussaint J, Singer AJ. 2014. The evaluation and management of thermal injuries: 2014 update. Clin Exp Emerg Med. 1:8–18.
   PubMedGoogle Scholar
• U.S Deparmant of Transport. 2016. 2016 Emergency Response Guidebook. U.S Department of Transport. available at : https://www.phmsa.dot.gov/sites/phmsa.dot.gov/files/docs/ERG2016.pdf
   Google Scholar
• van Helden HP, Kuijpers WC, Diemel RV. 2004. Asthmalike symptoms following intratracheal exposure of Guinea pigs to sulfur mustard aerosol: therapeutic efficacy of exogenous lung surfactant curosurf and salbutamol. Inhal Toxicol. 16:537–548.
   PubMed Web of Science ®Google Scholar
• Veress LA, Anderson DR, Hendry-Hofer TB, Houin PR, Rioux JS, Garlick RB, Loader JE, Paradiso DC, Smith RW, Rancourt RC, et al. 2015. Airway tissue plasminogen activator prevents acute mortality due to lethal sulfur mustard inhalation. Toxicol Sci. 143:178–184.
   PubMed Web of Science ®Google Scholar
• Veress LA, Hendry-Hofer TB, Loader JE, Rioux JS, Garlick RB, White CW. 2013. Tissue plasminogen activator prevents mortality from sulfur mustard analog-induced airway obstruction. Am J Respir Cell Mol Biol. 48:439–447.
   PubMed Web of Science ®Google Scholar
• Vijayaraghavan R, Kumar P, Dubey DK, Singh R. 2002. Evaluation of CC2 as a decontaminant in various hydrophilic and lipophilic formulations against sulphur mustard. Biomed Environ Sci. 15:25–35.
   PubMed Web of Science ®Google Scholar
• Vijayaraghavan R, Kumar P, Joshi U, Raza SK, Lakshmana Rao PV, Malhotra RC, Jaiswal DK. 2001. Prophylactic efficacy of amifostine and its analogues against sulphur mustard toxicity. Toxicology. 163:83–91.
   PubMed Web of Science ®Google Scholar
• Vojvodic V, Milosavljević Z, Bos˘ k. B, Bojanic N. 1985. The protective effect of different drugs in rats poisoned by sulfur and nitrogen mustards. Fundamental Appl Toxicol. 5:S160–S168.
   PubMedGoogle Scholar
• Weinberger B, Laskin JD, Sunil VR, Sinko PJ, Heck DE, Laskin DL. 2011. Sulfur mustard-induced pulmonary injury: therapeutic approaches to mitigating toxicity. Pulm Pharmacol Ther. 24:92–99.
   PubMed Web of Science ®Google Scholar
• Wigenstam E, Rocksen D, Ekstrand-Hammarstrom B, Bucht A. 2009. Treatment with dexamethasone or liposome-encapsuled vitamin E provides beneficial effects after chemical-induced lung injury. Inhal Toxicol. 21:958–964.
   PubMed Web of Science ®Google Scholar
• Wilde PE, Upshall DG. 1994. Cysteine esters protect cultured rodent lung slices from sulphur mustard. Hum Exp Toxicol. 13:743–748.
   PubMed Web of Science ®Google Scholar
• Willems JL. 1989. Clinical management of mustard gas casualties. Belgium: Heymans Institute of Pharmacology University of Ghent Medical School.
   Google Scholar
• Willems JL. 1989. Clinical Management of Mustard Gas Casualties. Ann Med Mil Belg 3:1–61.
   Google Scholar
• Williams RN, Bhattacherjee P. 1984. Inhibition of the acute ocular responses to nitrogen mustard by colchicine. Exp Eye Res. 39:721–729.
   PubMed Web of Science ®Google Scholar
• Wormser U, Brodsky B, Green BS, Arad-Yellin R, Nyska A. 1997. Protective effect of povidone-iodine ointment against skin lesions induced by sulphur and nitrogen mustards and by non-mustard vesicants. Arch Toxicol. 71:165–170.
   PubMed Web of Science ®Google Scholar
• Wormser U, Brodsky B, Green BS, Arad-Yellin R, Nyska A. 2001. Protective effect of povidone iodine ointment against skin lesions induced by chemical and thermal stimuli. J Appl Toxicol. 20: S183–S185.
   Google Scholar
• Wormser U, Brodsky B, Reich R. 2002. Topical treatment with povidone iodine reduces nitrogen mustard-induced skin collagenolytic activity. Arch Toxicol. 76:119–121.
   PubMed Web of Science ®Google Scholar
• Wormser U, Brodsky B, Sintov A. 2002. Skin toxicokinetics of mustard gas in the guinea pig: effect of hypochlorite and safety aspects. Arch Toxicol. 76:517–522.
   PubMed Web of Science ®Google Scholar
• Wormser U, Izrael M, Van der Zee EA, Brodsky B, Yanai J. 2005. A chick model for the mechanisms of mustard gas neurobehavioral teratogenicity. Neurotoxicol Teratol. 27:65–71.
   PubMed Web of Science ®Google Scholar
• Wormser U, Sintov A, Brodsky B, Casillas RP, Nyska A. 2004. Protective effect of topical iodine containing anti-inflammatory drugs against sulfur mustard-induced skin lesions. Arch Toxicol. 78:156–166.
   PubMed Web of Science ®Google Scholar
• Wormser U, Sintov A, Brodsky B, Nyska A. 2000. Topical iodine preparation as therapy against sulfur mustard-induced skin lesions. Toxicol Appl Pharmacol. 169:33–39.
   PubMed Web of Science ®Google Scholar
• Yourick JJ, Clark CR, Mitcheltree LW. 1991. Niacinamide pretreatment reduces microvesicle formation in hairless guinea pigs cutaneously exposed to sulfur mustard. Fundam Appl Toxicol. 17:533–542.
   PubMedGoogle Scholar
• Yourick JJ, Dawson JS, Mitcheltree LW. 1992. Sulfur mustard-induced microvesication in hairless guinea pigs: effect of short-term niacinamide administration. Toxicol Appl Pharmacol. 117:104–109.
   PubMed Web of Science ®Google Scholar
• Yourick JJ, Dawson JS, Mitcheltree LW. 1995. Reduction of erythema in hairless guinea pigs after cutaneous sulfur mustard vapor exposure by pretreatment with niacinamide, promethazine and indomethacin. J Appl Toxicol. 15:133–138.
   PubMed Web of Science ®Google Scholar
• Zarchi K, Akbar A, Naieni KH. 2004. Long-term pulmonary complications in combatants exposed to mustard gas: a historical cohort study. Int J Epidemiol. 33:579–581.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Riviere JE, Monteiro-Riviere NA. 1995. Evaluation of protective effects of sodium thiosulfate, cysteine, niacinamide and indomethacin on sulfur mustard-treated isolated perfused porcine skin. Chem Biol Interact. 96:249–262.
   PubMed Web of Science ®Google Scholar
• Zilker T, Felgenhauer N. 2002. S-mustard gas poisoning - experience with 12 victims. Clin Toxicol (Phila). 40:251.
   Google Scholar
• Zojaji R, Mazloum Farsi Baf M. 2015. Upper respiratory complications of sulfur mustard (SM) poisoning. In: Balali-Mood M, Abdollahi M, editors. Basic and clinical toxicology of mustard compounds. New York (NY): Springer; p. 153–171.
   Google Scholar